EICHOR
● Recruiting
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung · Sponsor: Janssen Research & Development, LLC
About this study
The main purpose of this study is to find out the most suitable dose (recommended phase 2 combination dose \[RP2CD\]) of amivantamab and olomorasib combination therapy and to assess how well the combination slows down or prevents the growth of tumors in participants with KRAS G12C mutant metastatic non-small cell lung cancer (NSCLC: the most common type of lung cancer; metastatic: has spread to other parts of the body; KRAS G12C mutant: mutation \[change\] in the kirsten rat sarcoma viral oncogene homolog \[KRAS\] gene in tumor cells in which glycine \[G\] at position 12 is replaced with cystine \[C\]).
This description comes directly from the study's public registry record.
Talk to the study team
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
Locations (13)
| New York University Langone Medical Center | New York, New York, United States | Recruiting |
| Oncology Consultants Cancer Center | Houston, Texas, United States | Suspended |
| Virginia Cancer Specialists | Fairfax, Virginia, United States | Recruiting |
| Princess Margaret Hospital | Toronto, Ontario, Canada | Recruiting |
| The First Affiliated Hospital Sun Yat sen University | Guangzhou, China | Recruiting |
| Harbin medical university cancer hospital | Harbin, China | Recruiting |
| Shanghai East Hospital | Shanghai, China | Recruiting |
| Severance Hospital Yonsei University Health System | Seoul, South Korea | Recruiting |
| Asan Medical Center | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi | Ankara, Turkey (Türkiye) | Recruiting |
| Ankara Bilkent Sehir Hastanesi | Çankaya, Turkey (Türkiye) | Recruiting |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07227025